American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

ASCO 2024 logo
  • May 31, 2024 - June 5, 2024
  • Chicago, IL, USA

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
Preliminary data from Biomica’s Phase 1 study of BMC128 will be showcased at the conference.

PRESENTATION DETAILS:
Title: Preliminary results from a First-in-Human (FIH), open-label Phase 1 study with BMC128, a rationally designed live bacterial consortium, in combination with nivolumab.
Session Type: Poster Session
Abstract Number: 8631
Date and Time: June 3, 2024, 1:30 PM – 4:30 PM (CDT)

For more information: https://conferences.asco.org/am/program

Back to all News

Highlighted News About Biomica

Jan 27, 2025

2025 J.P. Morgan Annual Healthcare week

Dr. Elran Haber, CEO of Biomica will be attending Biotech Showcase 2025 as part of the J.P. Morgan Annual Healthcare week in San Francisco. If you’d like to meet with Dr. Haber, please get in touch through the partnering platform or DM us.

Jan 27, 2025

Biomica’s Investor Meeting & Workshop

Biomica was delighted to host an inspiring investor meeting and workshop in Hong Kong, bringing together leading academics, local investors, researchers, and partners. Dr. Elran Haber, Biomica’s CEO, presented the company’s cutting-edge advancements in microbiome-based therapeutics, while Prof. Gal Markel shared his insights into the recent positive Ph1 results and the transformative potential of these […]

Jan 27, 2025

Microbiome Connect USA

Biomica’s CEO, Dr. Elran Haber, will be a featured panelist at the Microbiome Connect USA event on Wednesday, November 20, at 9:30 AM (local time). Join him for the session: “Taking the Bird’s Eye View: Market Insights & Dynamics of Microbiome Drug Development”.